Alzheimer’s disease has long resisted simple solutions, yet some of the most intriguing new leads are emerging from familiar ...

Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease ...

Aloe vera is widely known as a plant used to soothe burns and skin irritation, but it also contains many natural compounds that may affect processes inside the body. Researchers are now exploring ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering ...

Please provide your email address to receive an email when new articles are posted on . Cell transformation begins with slow degeneration and progresses rapidly. The data confirmed results from ...

Despite its strong influence, APOE is not the sole cause of Alzheimer’s or other dementias. Even among people with the highest genetic risk, those who carry two ε4 variants, lifetime risk of Alzheimer ...

Researchers connecting pieces of the massive Alzheimer's puzzle are closer to slotting the next one in place, with yet ...

CHICAGO (Reuters) -Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of blockbuster drugs Ozempic and Wegovy, but scientists are still ...

A protein that has long frustrated diabetes researchers is suddenly at the center of a very different fight. By targeting an enzyme called protein tyrosine phosphatase 1B, or PTP1B, scientists are ...

Highlights from CTAD 2025 include GLP-1 agonist data, p-tau217 biomarker utility, subcutaneous lecanemab trials, and racial disparities in trial enrollment.

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.